Peri implant disease is associated with two main entities - peri-implantitis and peri-implant mucositis. Peri-implant mucositis is an inflammatory reversible reaction in the soft tissues which surrounds the dental implant. Peri-implantitis is defined as an inflammatory reaction with results in the loss of bone surrounding the tissues and the dental implant.Anaerobic plaque bacteria can show a bad effect on peri-implant tissue health which can lead to peri-implantitis disease.

Market Analysis and Insights: Global Peri-implantitis Treatment Market
The global Peri-implantitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peri-implantitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peri-implantitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peri-implantitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peri-implantitis Treatment market.

Global Peri-implantitis Treatment Scope and Market Size
Peri-implantitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peri-implantitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgical Treatment
Drug Treatment

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Cadila Pharmaceuticals
R.N. Laboratories
Basic Pharma Life Science
Prachi Pharmaceuticals
Healthy Life Pharma
Geistlich Pharma
Dawood & Tanner